Article

Hope for RP in Herbal Remedy

Author(s):

Patients with the hereditary degenerative eye disease retinitis pigmentosa (RP) may delay their loss of daytime vision by taking a traditional Chinese plant remedy Lycium barbarum also known as goji berry or wolfberry.

Patients with the hereditary degenerative eye disease retinitis pigmentosa (RP) may delay their loss of daytime vision by taking a traditional Chinese plant remedy Lycium barbarum also known as goji berry or wolfberry, a team from Hong Kong reports.

In an abstract presented May 1 at the 2016 ARVO conference in Seattle, WA, Henry Chan and colleagues from the Hong Kong Polytechnic University, Hong Kong studied 23 patients who got either the remedy or placebo daily for 12 months.

They found the group that got Lycium barbarum (LB) showed less deterioration in contrast visual acuity as measured by several tests.

“Our results confirm that the 6 months LB treatment for RP patients had marginal significant improvement

in low-contrast VA and central visual sensitivity," the team said.

The plant has a neuroprotective effect believed to delay or minimize the deterioration of central visual function in RP,” they concluded..

Those visual acuity measurements showed that changes of 10% contrast visual acuity for the groups were -0.5 for the LB

group and 0.6 for the placebo group.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
A. Sidney Barritt, MD | Credit: UNC School of Medicine
© 2024 MJH Life Sciences

All rights reserved.